GORMAN KEVIN CHARLES (Chief Executive Officer) exercised options at NEUROCRINE BIOSCIENCES INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/3/2026ACC: 0001201096-26-000003
DirectorOfficer· Chief Executive Officer
Since Feb 2019
-2.85K
Net shares
Net seller
$387.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
5.14K acquired · 7.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.14K
Price / share
—
Trade value
—
% of position
1.0%
1/31/2026
514.60K→519.74K
Common Stock
Direct
Shares
−2.85K
Price / share
$136.06
Trade value
$387.09K
% of position
0.5%
1/31/2026
519.74K→516.89K
Total
Net shares
+2.30K
Net value
-$387.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | M · Option Exercise | +5.14K | — | — | 1.0% | 514.60K | 519.74K |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −2.85K | $136.06 | $387.09K | 0.5% | 519.74K | 516.89K |
| Total | +2.30K | -$387.09K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
5.14K shares
Shares
−5.14K
Strike price
Held after
0.00
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock5.14K shares | 1/31/2026 | M · Option Exercise | −5.14K | — | 0.00 |